INS and cirrhosis of liver: Notably, when administering SGLT2is to patients with low insulin secretion who are not administering extrinsic insulin, serum ketone concentrations may increase or ketoacidosis may occur, and this is particularly true when administering these drugs to patients with liver cirrhosis.